Header Logo

Connection

JEFFREY E GERSHENWALD to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Drug Administration Schedule.
JEFFREY E GERSHENWALD
Connection Strength
0.022
Drug Administration Schedule
  1. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy. J Clin Oncol. 2016 Apr 01; 34(10):1079-86.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.